Ginkgo biloba, one of the oldest known medicinal plants, is gaining renewed attention for its powerful vascular benefits.
Originally from China, this plant has compounds that may reduce swelling and improve blood flow.
Improves blood circulation
Ginkgo biloba promotes better blood flow by dilating blood vessels, making it easier for blood to return to the heart.
This is especially helpful for people with poor venous function.
Reduces varicose vein swelling
Its anti-inflammatory properties help reduce the swelling and discomfort caused by blood pooling in veins, which is common in varicose vein cases.
Strengthens vein walls
Thanks to flavonoids and terpenoids, ginkgo helps reinforce the walls of blood vessels, making them more resilient to pressure and damage.
Eases heaviness in legs
The plant can alleviate the sensation of heavy, tired legs – a common symptom of chronic venous insufficiency and enlarged varicose veins.
Acts as a strong antioxidant
Ginkgo functions as a potent antioxidant, protecting blood vessels and tissue from free radicals, which are associated with aging and inflammation.
Prevents blood clot formation
Ginkgo’s ginkgolides inhibit platelet aggregation, meaning they reduce the risk of dangerous blood clots forming in veins or arteries.
Useful for those at risk of thrombosis
For individuals with a history of deep vein thrombosis or cardiovascular risk, ginkgo biloba may provide preventative support – under medical supervision.
Enhances cognitive function
In addition to its vascular advantages, ginkgo is known to improve memory and focus, making it a potential supplement for age-related cognitive decline.
Fights cellular aging
Its antioxidant properties combat oxidative stress, helping to slow the process of cellular aging and promote overall vitality.
Should be used with caution
Despite its benefits, ginkgo biloba must be taken with care – especially by people on blood-thinning medications, as it may increase the risk of bleeding.
Always consult a doctor first.
This article is based on information from Infobae.